Early fusion combines raw or engineered measurements before modeling, allowing the system to analyze modalities jointly from the outset. Intermediate fusion first transforms each modality into a learned representation, then combines those representations. Late fusion keeps modality-specific predictions separate until the final stage. These choices determine where information is integrated and how modality-specific structure contributes to the result.
Medical images, clinical records, laboratory measurements, and genomic profiles encode information in different scales and formats. Alignment and compatible feature handling are therefore necessary before their information can be combined meaningfully. Without this step, relationships among modalities may be difficult to analyze, limiting the ability to connect anatomical, biological, and clinical signals in one assessment.
Missing information is a central consideration because patients may not have every modality available, such as imaging, laboratory data, clinical records, or genomic profiles. Fusion strategies must address these gaps when aligning and combining modality-specific information. Handling incomplete inputs helps preserve the usefulness of the overall analysis for diagnosis, prognosis, treatment selection, or monitoring.
Each modality can describe a different aspect of a patient's condition. Medical images contribute anatomical information, genomic profiles and laboratory measurements provide biological signals, and clinical records add patient-related context. Combining these complementary perspectives can support a more complete analysis than considering one source alone, strengthening applications that depend on linked evidence across disease and patient characteristics.
A typical workflow begins by identifying relevant sources, such as images, clinical records, laboratory measurements, or genomic profiles. The information is then aligned despite differences in scale and format, followed by early, intermediate, or late integration. The combined analysis can subsequently support disease detection, diagnosis, prognosis, treatment selection, or patient monitoring.
Multimodal fusion is especially relevant when no single source captures the full clinical picture. Linking imaging with records, laboratory measurements, or genomic profiles can provide information spanning anatomy, biology, and patient context. This broader evidence base is useful for disease detection and diagnosis, as well as for estimating prognosis, selecting treatments, and monitoring patients over time.
By connecting patient-specific clinical information with anatomical, laboratory, and genomic signals, multimodal fusion can support decisions tailored to an individual's disease profile and observed condition. Its outputs may inform diagnosis, prognosis, treatment selection, and ongoing monitoring. In this way, the approach links diverse evidence to clinical decision-making and advances more personalized healthcare.